收藏切换
Research advances in epidemiological situation and diagnosis and treatment of metabolism-associated fatty liver disease
收藏切换
PDF
Ying-Jie Zhuang1, Wen-Hui Liu1, Zheng-Yi Liu1, 2, Li-Li Gao1, *
Medical Journal of Chinese People’s Liberation Army | 2023, 48(12) : 1457 - 1466
Less
收藏切换
Medical Journal of Chinese People’s Liberation Army | 2023, 48(12): 1457-1466
Review
Research advances in epidemiological situation and diagnosis and treatment of metabolism-associated fatty liver disease
Full
Ying-Jie Zhuang1, Wen-Hui Liu1, Zheng-Yi Liu1, 2, Li-Li Gao1, *
Affiliations
  • 1Department of Gastroenterology, the Second Medical Center of Chinese PLA General Hospital/ National Clinical Medical Research Center for Geriatric Diseases, Beijing 100853, China
  • 2Chinese PLA Medical School, Beijing 100853, China
Published: 2023-12-28 doi: 10.11855/j.issn.0577-7402.0545.2023.0807
Outline
收藏切换

Metabolism-associated fatty liver disease (MAFLD), formerly known as non-alcoholic fatty liver disease (NAFLD), is one of the most popular chronic liver diseases in the world, and has become one of the main causes of liver cirrhosis, end-stage liver disease, and primary liver cancer. In recent years, the prevalence of MAFLD has gradually increased in China, the Asia Pacific region, and even globally, increasing the medical and socio-economic burden. The exploration of the epidemiology and risk factors of this disease at home and abroad has also gradually increased. Meanwhile, due to the scarcity of MAFLD treatment drugs, their drug treatment has become a hot issue that needs to be urgently addressed in clinical practice. In recent years, there has been an increase in the number of drugs entering the clinical trial stage. Based on this, the current epidemiological status, risk factors, diagnostic criteria, and treatment research progress of MAFLD have been reviewed in order to provide new ideas and directions for the clinical diagnosis, treatment, and scientific research of MAFLD.

non-alcoholic fatty liver disease  /  epidemiology  /  risk factors  /  diagnosis  /  therapeutics
Ying-Jie Zhuang, Wen-Hui Liu, Zheng-Yi Liu, Li-Li Gao. Research advances in epidemiological situation and diagnosis and treatment of metabolism-associated fatty liver disease[J]. Medical Journal of Chinese People’s Liberation Army, 2023 , 48 (12) : 1457 -1466 . DOI: 10.11855/j.issn.0577-7402.0545.2023.0807
  • National Natural Science Foundation of China(81570563)
Year 2023 volume 48 Issue 12
PDF
266
110
Cite this Article
BibTeX
Article Info
doi: 10.11855/j.issn.0577-7402.0545.2023.0807
  • Receive Date:2023-04-17
  • Online Date:2025-11-24
  • Published:2023-12-28
Article Data
Affiliations
History
  • Received:2023-04-17
  • Accepted:2023-06-12
Funding
National Natural Science Foundation of China(81570563)
Affiliations
    1Department of Gastroenterology, the Second Medical Center of Chinese PLA General Hospital/ National Clinical Medical Research Center for Geriatric Diseases, Beijing 100853, China
    2Chinese PLA Medical School, Beijing 100853, China

Corresponding:

References
Share
https://castjournals.cast.org.cn/joweb/jfjyxzz/EN/10.11855/j.issn.0577-7402.0545.2023.0807
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数

Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)

Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT